Drug:
Reaction: HAEMORRHAGE
20250101 - 20251231
No. 401 - 500
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
401 | 25092757 |
US |
7 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
402 | 25092773 |
IT |
60 | 1 |
Haemoglobin decreased, Haemorrhage, Tooth disorder, Arterial perforation, |
||||
RIVAROXABAN, |
||||
403 | 25092827 |
US |
72 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
404 | 25092987 |
US |
76 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
405 | 25093328 |
CA |
||
Haemorrhage, Product dose omission issue, |
||||
EMICIZUMAB, |
||||
406 | 25093372 |
US |
55 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
407 | 25093431 |
US |
25 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
408 | 25093441 |
US |
67 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
409 | 25093513 |
US |
59 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
410 | 25093629 |
GB |
36 | 2 |
Ectopic pregnancy, Maternal exposure during pregnancy, Disease risk factor, Haemorrhage, |
||||
UPADACITINIB, |
||||
411 | 25093891 |
US |
47 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
412 | 25093903 |
US |
40 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
413 | 25094055 |
US |
13 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
414 | 25094056 |
US |
73 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN ASPART, INSULIN LISPRO, |
||||
415 | 25094102 |
US |
19 | 2 |
Haemorrhage, Erythema, Condition aggravated, Dry skin, Dry eye, Pruritus, Eye pruritus, Ocular hyperaemia, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
416 | 25094412 |
US |
54 | 2 |
Haemorrhage, Visual impairment, |
||||
INSULIN LISPRO, |
||||
417 | 25095086 |
US |
1 | |
Haemorrhage, Haemorrhage, |
||||
MELOXICAM, |
||||
418 | 25095433 |
CN |
1 | |
Mouth haemorrhage, Haemarthrosis, Gastrointestinal haemorrhage, Abdominal pain, Anti factor VIII antibody increased, Haemorrhage, Vomiting, Arthralgia, Joint swelling, Erythema, Physical disability, Heart rate increased, Palpitations, Pain, |
||||
419 | 25095709 |
AT |
1 | |
Haemorrhage, |
||||
AVAPRITINIB, |
||||
420 | 25096027 |
US |
1 | |
Hospitalisation, Haemorrhage, |
||||
421 | 25096345 |
US |
71 | 1 |
Haemorrhage, Discomfort, Pain, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
422 | 25096411 |
TH |
66 | 1 |
Haemorrhage, |
||||
IRINOTECAN HYDROCHLORIDE, |
||||
423 | 25096544 |
US |
1 | |
Haemorrhage, Drug ineffective, Diarrhoea, Gastrointestinal pain, |
||||
ADALIMUMAB, |
||||
424 | 25096652 |
CA |
57 | 2 |
Leukaemia, Nausea, Diarrhoea, Melanocytic hyperplasia, Administration site pain, Inappropriate schedule of product administration, Haemorrhage, Scar, Incorrect product administration duration, Needle issue, Infusion site swelling, Infusion site erythema, Infusion site mass, Infusion site pain, Incorrect dose administered, |
||||
IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PRAMIPEXOLE DIHYDROCHLORIDE, |
||||
425 | 25097102 |
US |
18 | 1 |
Joint injury, Haemorrhage, |
||||
426 | 25099135 |
2 | ||
Haemorrhage, Therapy interrupted, |
||||
TADALAFIL, TREPROSTINIL, SOTATERCEPT-CSRK, AMBRISENTAN, |
||||
427 | 25099312 |
|||
Haemorrhage, Endometrial thickening, |
||||
428 | 25086724 |
DE |
81 | 1 |
Liposarcoma, Haemorrhage, Epistaxis, Paralysis, Liposarcoma, Liposarcoma, Blood test abnormal, Product dose omission issue, Vaccination site pain, |
||||
RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
429 | 25086737 |
US |
56 | 2 |
Angina pectoris, Malabsorption, Vitamin B12 deficiency, Hypertension, Dysphagia, Lymphadenopathy, Haemorrhoids, Arthralgia, Hypokalaemia, Hypothyroidism, Rectal haemorrhage, Myoclonus, Thyroid atrophy, Haemorrhage, Gastrooesophageal reflux disease, Proctalgia, Transient ischaemic attack, Atrial fibrillation, Fibromyalgia, Osteoporosis, |
||||
LINACLOTIDE, METHOTREXATE SODIUM, METHOCARBAMOL, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, ATENOLOL, SULFASALAZINE, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, ZAVEGEPANT, ETANERCEPT, OMEPRAZOLE MAGNESIUM, METHYLPREDNISOLONE ACETATE, TOPIRAMATE, GALANTAMINE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, ONABOTULINUMTOXINA, DICLOFENAC SODIUM, CLONAZEPAM, ATORVASTATIN CALCIUM, ERGOCALCIFEROL, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METHYLPHENIDATE HYDROCHLORIDE, |
||||
430 | 25086905 |
US |
1 | |
Tooth disorder, Loose tooth, Haemorrhage, |
||||
EMPAGLIFLOZIN, |
||||
431 | 25086947 |
US |
53 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, DULAGLUTIDE, INSULIN GLARGINE, |
||||
432 | 25086965 |
JP |
1 | |
Haemorrhage, |
||||
433 | 25087239 |
US |
66 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
434 | 25087413 |
US |
77 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
435 | 25087816 |
US |
68 | 1 |
Abdominal discomfort, Dry skin, Haemorrhage, Discharge, Eye irritation, Skin exfoliation, Dry skin, Balance disorder, Agitation, Sleep disorder, Pruritus, Skin fissures, |
||||
TRALOKINUMAB-LDRM, VALACYCLOVIR HYDROCHLORIDE, PREDNISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
436 | 25087907 |
US |
60 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
437 | 25088011 |
JP |
7 | 1 |
Haemorrhage, |
||||
TOCILIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, HEPARIN SODIUM, |
||||
438 | 25088186 |
MY |
||
Haemorrhage, Oral neoplasm, |
||||
RIVAROXABAN, |
||||
439 | 25088263 |
SK |
||
Off label use, Retinal haemorrhage, Haemorrhage, |
||||
BEVACIZUMAB, AFLIBERCEPT, |
||||
440 | 25088524 |
US |
59 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO-AABC, INSULIN DEGLUDEC, |
||||
441 | 25088994 |
US |
1 | |
Pericarditis, Catheterisation cardiac abnormal, Left ventricular hypertrophy, Hypotension, Nausea, Abdominal discomfort, Diarrhoea, Dyspnoea exertional, Supraventricular tachycardia, Hypercholesterolaemia, Contusion, Haemorrhage, Dyspnoea, Fatigue, Drug interaction, |
||||
TAFAMIDIS, ROSUVASTATIN, DAPAGLIFLOZIN, |
||||
442 | 25089077 |
US |
65 | 1 |
Blood disorder, Contusion, Haemorrhage, Inflammation, Skin laceration, Injection site haemorrhage, Injection site pruritus, Injection site pain, Injection site irritation, Injection site erythema, Drug interaction, |
||||
APIXABAN, RILONACEPT, RILONACEPT, |
||||
443 | 25089448 |
CA |
84 | 1 |
Tooth extraction, Haemorrhage, |
||||
ZOLEDRONIC ACID, |
||||
444 | 25089472 |
US |
57 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
445 | 25089529 |
US |
22 | 1 |
Haemorrhage, Dysgeusia, Contusion, |
||||
GIVINOSTAT, |
||||
446 | 25089679 |
US |
69 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
447 | 25089863 |
US |
70 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO-AABC, |
||||
448 | 25090813 |
US |
2 | |
Anaemia, Haemorrhage, |
||||
RIVAROXABAN, |
||||
449 | 25091098 |
US |
55 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
450 | 25091161 |
CN |
26 | 2 |
Abortion, Monoplegia, Haemorrhage, Off label use, |
||||
MISOPROSTOL, |
||||
451 | 25091557 |
US |
2 | |
Haemorrhage, |
||||
DUPILUMAB, |
||||
452 | 25091567 |
US |
67 | 1 |
Blood pressure abnormal, Rash macular, Dry skin, Haemorrhage, Skin exfoliation, Pruritus, Dizziness, Endodontic procedure, Product dose omission in error, |
||||
DUPILUMAB, APIXABAN, LISINOPRIL, |
||||
453 | 25092015 |
GB |
74 | 2 |
Haemorrhage, Unevaluable event, Malaise, Head injury, |
||||
RISANKIZUMAB-RZAA, |
||||
454 | 25092046 |
CA |
2 | |
Diarrhoea, Haemorrhage, Colitis ulcerative, |
||||
UPADACITINIB, |
||||
455 | 25081758 |
US |
1 | |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
456 | 25081759 |
US |
22 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
457 | 25081763 |
CN |
1 | |
Haemarthrosis, Disability, Haemophilic arthropathy, Haemarthrosis, Haemorrhage, |
||||
458 | 25081793 |
US |
73 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
459 | 25081811 |
IT |
||
Cardiotoxicity, Haemorrhage, |
||||
IBRUTINIB, |
||||
460 | 25082446 |
CA |
69 | 1 |
Haemoglobin decreased, Chest discomfort, Haemorrhage, |
||||
RISANKIZUMAB-RZAA, |
||||
461 | 25082524 |
US |
11 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
462 | 25082556 |
CN |
59 | 1 |
Eye pain, Headache, Vomiting, Visual acuity reduced, Ocular hyperaemia, Nausea, Conjunctival hyperaemia, Intraocular pressure increased, Vitreous haze, Retinal haemorrhage, Glaucoma, Vitreous opacities, Haemorrhage, Infection, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
463 | 25082720 |
US |
7 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
464 | 25082741 |
US |
1 | |
Haemorrhage, |
||||
465 | 25082849 |
US |
65 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
466 | 25082912 |
US |
1 | |
Haemorrhage, Pain, |
||||
UPADACITINIB, |
||||
467 | 25083314 |
CA |
39 | 1 |
Haematochezia, Haemorrhage, Decreased appetite, Fatigue, Drug ineffective, Off label use, Diarrhoea, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, INFLIXIMAB-DYYB, METRONIDAZOLE, METOPROLOL TARTRATE, METOPROLOL, AZATHIOPRINE, |
||||
468 | 25083442 |
US |
75 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
469 | 25083815 |
US |
67 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
470 | 25083820 |
US |
45 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
471 | 25083877 |
US |
1 | |
Haemorrhage, Neck pain, Nephrolithiasis, Haematuria, Swelling, |
||||
EMICIZUMAB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, |
||||
472 | 25083889 |
US |
44 | 2 |
Haemorrhage, Asthenia, Fatigue, Abdominal pain upper, Haematochezia, Epistaxis, Haematemesis, Gait inability, Sjogren^s syndrome, Loss of consciousness, |
||||
RIOCIGUAT, RIOCIGUAT, WATER, STERILE WATER, STERILE WATER FOR INJECTION, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, CETIRIZINE HYDROCHLORIDE, FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ACETAMINOPHEN, ROMIPLOSTIM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, EPOPROSTENOL, IRON, HYDROXYCHLOROQUINE SULFATE, AMBRISENTAN, SPIRONOLACTONE, PREDNISONE, OXYGEN, 0XYGEN, AMBRISENTAN, |
||||
473 | 25083997 |
CN |
66 | 1 |
Haematuria, Haemorrhage, Prothrombin time prolonged, Activated partial thromboplastin time prolonged, |
||||
ALTEPLASE, |
||||
474 | 25084385 |
US |
1 | |
Haemorrhage, Arthralgia, |
||||
475 | 25084475 |
US |
63 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
476 | 25084503 |
US |
51 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
477 | 25084571 |
FR |
77 | 2 |
Confusional state, Agitation, Hallucination, Somnolence, Aggression, Hypokalaemia, Hypophosphataemia, Persecutory delusion, Haemorrhage, Choking, Pulmonary congestion, Head injury, Fall, Encephalopathy, Clostridium difficile colitis, Off label use, |
||||
CLONAZEPAM, CLONAZEPAM, OLANZAPINE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, OXAZEPAM, OXAZEPAM, METHADONE HYDROCHLORIDE, METHADONE, METHADONE HYDROCHLORIDE, METHADONE, METHYLPREDNISOLONE, MORPHINE SULFATE, APIXABAN, IRBESARTAN, NALOXEGOL OXALATE, LANSOPRAZOLE, AMLODIPINE, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE, BEVACIZUMAB, FLUOROURACIL, FLUOROURACIL, OXALIPLATIN, |
||||
478 | 25084760 |
US |
64 | 1 |
Thrombosis, Blood urine present, Haemorrhage, Nephrolithiasis, Product dose omission issue, Depressed mood, |
||||
PACRITINIB, |
||||
479 | 25085338 |
US |
69 | 1 |
Pain, Discomfort, Haemorrhage, Skin injury, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
480 | 25085365 |
US |
1 | |
Haemorrhage, Expired product administered, |
||||
MAGNESIUM HYDROXIDE, |
||||
481 | 25085692 |
JP |
84 | 1 |
Stevens-Johnson syndrome, Haemorrhage, Product use in unapproved indication, |
||||
LANSOPRAZOLE, NICARDIPINE, |
||||
482 | 25085737 |
FI |
38 | 2 |
Suicidal ideation, Haemorrhage, Heavy menstrual bleeding, Stress, Depression, Tearfulness, |
||||
LEVONORGESTREL, LEVOTHYROXINE, |
||||
483 | 25086107 |
US |
41 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
484 | 25086109 |
US |
52 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
485 | 25086272 |
US |
72 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, SEMAGLUTIDE, |
||||
486 | 25086527 |
US |
69 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
487 | 25086542 |
US |
84 | 2 |
Haemorrhage, Skin discolouration, |
||||
APIXABAN, APIXABAN, |
||||
488 | 25086614 |
US |
77 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
489 | 25086615 |
US |
74 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
490 | 25089139 |
92 | 1 | |
Haemorrhage, Haematuria, Red blood cell transfusion, |
||||
APIXABAN, |
||||
491 | 25089345 |
77 | 1 | |
Haemorrhage, Abdominal wall haematoma, Cardiogenic shock, Multiple organ dysfunction syndrome, Hospice care, |
||||
HEPARIN SODIUM AND DEXTROSE, |
||||
492 | 25089724 |
38 | 1 | |
Haemorrhage, |
||||
RIVAROXABAN, |
||||
493 | 25081384 |
US |
45 | 1 |
Haemorrhage, |
||||
494 | 25081421 |
US |
69 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
495 | 25081518 |
US |
15 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
496 | 25081523 |
US |
75 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
497 | 25081524 |
US |
71 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
498 | 25081537 |
US |
78 | 1 |
Haemorrhage, |
||||
INSULIN HUMAN, |
||||
499 | 25081555 |
US |
50 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
500 | 25081556 |
US |
73 | 2 |
Haemorrhage, Contusion, |
||||
INSULIN LISPRO, INSULIN HUMAN, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28